We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Mammography SPECT With Rotating Slant Hole Collimator

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00328354
Recruitment Status : Unknown
Verified January 2006 by Johns Hopkins University.
Recruitment status was:  Not yet recruiting
First Posted : May 19, 2006
Last Update Posted : May 19, 2006
Information provided by:

Study Description
Brief Summary:
The goal is to conduct a pilot study to determine the feasibility of the clinical use of RMSSH SPECT imaging technology for breast imaging and to develop a standardized clinical protocol.

Condition or disease
Breast Cancer

Detailed Description:
The goal of this protocol is to develop and evaluate a novel SPECT imaging technique for imaging the breast using rotating multi-segment slant-hole (RMSSH) collimators. The motivation is the requirement of a low cost RMSSH collimator and a conventional LFOV camera. It is believed that RMSSH SPECT is particularly suitable for applications in breast imaging.

Study Design

Study Type : Observational
Estimated Enrollment : 20 participants

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mammography
U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   35 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Women seen at Johns Hopkins Avon Division of Breast Imaging who have been diagnosed with breast cancer.

Exclusion Criteria:

  • Pregnant (or possibly pregnant)
  • Lactating
  • Unable to give consent
  • Weights over 300 pounds
  • Women who have already undergone definitive surgical treatment to their breast for breast cancer will not be eligible.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00328354

Contact: Linda Wilkins, RT, CCRP 410-955-8216 lwilkins@jhmi.edu

United States, Maryland
Johns Hopkins Outpatient Center Not yet recruiting
Baltimore, Maryland, United States, 21287
Sponsors and Collaborators
Johns Hopkins University
Principal Investigator: Benjamin Tsui, Ph.D. Johns Hopkins University
More Information

ClinicalTrials.gov Identifier: NCT00328354     History of Changes
Other Study ID Numbers: R01 EB 0019-83 Mammography
First Posted: May 19, 2006    Key Record Dates
Last Update Posted: May 19, 2006
Last Verified: January 2006